| Patents for A61K 38 - Medicinal preparations containing peptides (316,240) |
|---|
| 08/31/2011 | EP1402015B1 A soluble complex comprising a retroviral surface glycoprotein and fkpa or slyd |
| 08/31/2011 | EP1270642B1 Branched polyalkylene glycols |
| 08/31/2011 | EP1095140B1 Neurotrophic factors |
| 08/31/2011 | CN1962695B GLP-1 infusion proteins, their preparation and use |
| 08/31/2011 | CN1824289B Use of substance P for mobilization or proliferation of mesenchymal stem cells and for wound healing or accelerating wound healing |
| 08/31/2011 | CN102171343A FGFR extracellular domain acidic region muteins |
| 08/31/2011 | CN102171340A MELK epitope peptides and vaccines containing the same |
| 08/31/2011 | CN102171249A Long-acting interferons and derivatives thereof and methods thereof |
| 08/31/2011 | CN102171246A Novel octapeptide compounds derived from somatostatin and therapeutic use thereof |
| 08/31/2011 | CN102171245A Halogen-stabilized insulin |
| 08/31/2011 | CN102171240A Methods of treating inflammation |
| 08/31/2011 | CN102171238A Treatment of biofilms |
| 08/31/2011 | CN102171186A Treatment or prevention of hepatitis c with immunomodulator compounds |
| 08/31/2011 | CN102170919A Tissue plug |
| 08/31/2011 | CN102170910A Novel use application of sugar chain-recognizing receptor |
| 08/31/2011 | CN102170908A Delivery of a CD40 agonist to a tumor draining lymph node of a subject |
| 08/31/2011 | CN102170901A Composition of tumor-associated peptides and related anti-cancer vaccine for the treatment of glioblastoma (GBM) and other cancers |
| 08/31/2011 | CN102170900A Novel immunotherapy against several tumors including neuronal and brain tumors |
| 08/31/2011 | CN102170899A Peptide sequences, their branched form and use thereof for antimicrobial applications |
| 08/31/2011 | CN102170898A Compositions and methods for treatment of radiation exposure |
| 08/31/2011 | CN102170897A Vaccine containing amb a 1 for treating allergy to ragweed |
| 08/31/2011 | CN102170896A Truncated analogues of glucose-dependent insulinotropic polypeptide |
| 08/31/2011 | CN102170895A Glucose-dependent insulinotropic polypeptide analogues |
| 08/31/2011 | CN102170868A Parenteral composition comprising microspheres with a diameter between 10 and 20 microns |
| 08/31/2011 | CN102168076A An ubiquitin ligase and the application thereof |
| 08/31/2011 | CN102167747A Entamoeba histolytica galactose/acetylgalactosamine (Gal/GalNAc) polypeptide fragment, and preparing method and application of polypeptide fragment |
| 08/31/2011 | CN102167736A Green mud crab antibacterial peptide Sphistin and application thereof |
| 08/31/2011 | CN102167734A High-efficiency expression and application of recombinant mutant tenebrio molitor antibacterial peptide |
| 08/31/2011 | CN102167730A Conotoxin analog Glu-Con-G[1-13], and design and synthesis method and application thereof |
| 08/31/2011 | CN102167729A Conotoxin analog Glu-Con-G (Glutamate-Conantokin-G) with morphine-dependent resistance and analgesic effect |
| 08/31/2011 | CN102166348A Application of inhibin recombinant fusion protein to preparing medicines for promoting oestrus and hybridization of sows |
| 08/31/2011 | CN102166347A New medicinal application of interleukin-12 |
| 08/31/2011 | CN102166346A Lrrc10 micromolecules and application thereof to preparation of medicaments for treating myocardial hypertrophy |
| 08/31/2011 | CN102166345A Medicinal composition containing small amount of desmopressin |
| 08/31/2011 | CN102166344A Method for building rat uveitis model |
| 08/31/2011 | CN102166226A Production process of posterior pituitary solution |
| 08/31/2011 | CN102166201A Oral ciclosporin A sustained-release agent and preparation method thereof |
| 08/31/2011 | CN102166200A Freeze-drying composition containing cerebroprotein hydrolysates and preparation method of freeze-drying composition |
| 08/31/2011 | CN102166187A Recombinant human endostatin sustained-release injection oil preparation and preparation process thereof |
| 08/31/2011 | CN102166186A More stable nitrogen heterocyclic peptide preparation |
| 08/31/2011 | CN102166183A Immunologic stimulant oral syrup and preparation method thereof |
| 08/31/2011 | CN101797232B Method for preparing small-granularity recombination human vascular endothelium inhibin slowly-released particle for injection |
| 08/31/2011 | CN101773660B Medicament containing anubi-polypeotide |
| 08/31/2011 | CN101768209B Hypotensive peptide with high in-vivo activity and preparation and purification method thereof |
| 08/31/2011 | CN101367871B Snake venom protein component of ahylysantinfarctase at southern Anhui Province, extraction method and uses thereof |
| 08/31/2011 | CN101353377B Zone 1 protein of programmed cell death protein 2 analogue and uses thereof |
| 08/30/2011 | US8008471 Nucleic acids for inhibiting hairless protein expression and methods of use thereof |
| 08/30/2011 | US8008470 Integrase cofactor |
| 08/30/2011 | US8008460 Polynucleotide fragments of an infectious human endogenous retrovirus |
| 08/30/2011 | US8008453 immunoglobulin domain peptides having myostatin, erythropoietin or thrombopoietin peptides as an internal sequence, preferably in a loop region of the domain; antibodies |
| 08/30/2011 | US8008451 Antibodies to TNF (tumor necrosis factor) receptor family members |
| 08/30/2011 | US8008443 Modulation of antibody effector function by hinge domain engineering |
| 08/30/2011 | US8008440 Combinatorial synthesis of libraries of macrocyclic compounds useful in drug discovery |
| 08/30/2011 | US8008438 High affinity NY-ESO T cell receptors |
| 08/30/2011 | US8008435 Polymer stabilized neuropeptides |
| 08/30/2011 | US8008433 Methods for preventing or treating bone disorders |
| 08/30/2011 | US8008431 Tumor-associated peptides that bind to MHC-molecules |
| 08/30/2011 | US8008357 Method for controlling average pore diameter of porous body comprising apatite/collagen composite fibers |
| 08/30/2011 | US8008351 Methods for prophylaxis or treatment of conditions associated with cortical spreading depression |
| 08/30/2011 | US8008333 Inducing ovulation; increasing response to follicle stimulating hormone |
| 08/30/2011 | US8008276 Use of zwitterionic polysaccharides for the specific modulation of immune processes |
| 08/30/2011 | US8008270 Antiviral oligonucleotides targeting viral families |
| 08/30/2011 | US8008269 Antiviral oligonucleotides |
| 08/30/2011 | US8008265 Vaccines, immunotherapeutics and methods for using the same |
| 08/30/2011 | US8008263 Organic compounds and their uses |
| 08/30/2011 | US8008262 β-peptides |
| 08/30/2011 | US8008261 Methods of reducing trail-induced apoptosis by trail isoforms |
| 08/30/2011 | US8008260 Methods of protecting against apoptosis using lipopeptides |
| 08/30/2011 | US8008259 Neurotrophin-derived peptide sequences |
| 08/30/2011 | US8008258 Cop 1 for treatment of inflammatory bowel diseases |
| 08/30/2011 | US8008256 Disintegrin and microtubule stabilizing agent (small molecule cell division inhibitor); preventing metastasis |
| 08/30/2011 | US8008255 Methods and compositions for enhanced transmucosal delivery of peptides and proteins |
| 08/30/2011 | US8008254 Methods and compositions for the repair and/or regeneration of damaged myocardium |
| 08/30/2011 | US8008253 Treatment for anxiety |
| 08/30/2011 | US8008252 Factor VII: remodeling and glycoconjugation of Factor VII |
| 08/30/2011 | US8008251 Macrocyclic inhibitors of hepatitis C virus |
| 08/30/2011 | US8008249 Neuregulins for prevention and treatment of damage from acute assault on vascular and neuronal tissue and as regulators of neuronal stem cell migration |
| 08/30/2011 | US8008077 Photochemical internalization for delivery of molecules into the cytosol |
| 08/30/2011 | US8008074 Compositions and methods for improving bone mass through modulation of receptors of PTH and fragments thereof |
| 08/30/2011 | US8008036 Method for identifying autistic individuals amenable to digestive enzyme therapy |
| 08/30/2011 | US8008027 Methods of screening for compounds that modulate the activity of ADEC, a chemokine expressed in inflamed adenoid |
| 08/30/2011 | US8008025 Biomarkers for neurodegenerative disorders |
| 08/30/2011 | US8007997 Methods and compositions for inhibiting the growth of hematopoietic malignant cells |
| 08/30/2011 | US8007850 Method for making a powder containing crystalline particles of glucopyranosyl-alditols |
| 08/30/2011 | US8007813 CD95-Fc fusion proteins |
| 08/30/2011 | US8007810 HLA-A2 tumor associated antigen peptides and compositions |
| 08/30/2011 | US8007809 Activin-actrii antagonists and uses for increasing red blood cell levels |
| 08/30/2011 | US8007808 Composition and method for facilitating the internalization of a therapeutic agent into a cell |
| 08/30/2011 | US8007805 Chimeric antigens for breaking host tolerance to foreign antigens |
| 08/30/2011 | US8007804 Complement receptor 2 targeted complement modulators |
| 08/30/2011 | US8007799 Vascular endothelial cell growth factor antagonists and uses thereof |
| 08/30/2011 | US8007798 Treatment of complement-associated disorders |
| 08/30/2011 | US8007790 Using modulator of tumor necrosis factor (TNF) pathway such as infliximab, simvastatin; drug screening |
| 08/30/2011 | US8007787 Human cystathionine β-synthase variants and methods of production thereof |
| 08/30/2011 | US8007786 Radioprotective SOD soluble isoform and uses thereof |
| 08/30/2011 | US8007781 Molecular vaccine linking an endoplasmic reticulum chaperone polypeptide to an antigen |
| 08/30/2011 | US8007777 Controlled release system composition for administration of a biological component, preferably, a probiotic bacterium |
| 08/30/2011 | US8007776 Vaccine composition comprising interleukin-15 (IL-15) |
| 08/30/2011 | US8007770 Purified linear polypeptide epitopes from walnuts and associated methods |
| 08/30/2011 | CA2545880C Erythropoietin solution formulation |